Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-004523

Chief Business Development Off sold 417 shares at $69.00 ($28,773)

  • Chief Business Development Off acquired 417 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

BENZENO SHARON · Chief Business Development Off

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-01-19 Exercise or conversion : show line 1 in the form +417 $6.27 $2,615 417 D
2021-01-19 Sale : show line 2 in the form −417 $69.00 $28,773 0 D
Open-market sales · 417 sh · avg $69.00 · $28,773

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-01-19 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −417 1,250 D
Loading xslF345X03/doc4.xml…